These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33964437)

  • 41. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors.
    Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A
    Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
    Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
    Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and cytotoxicity screening of 5-aryl-3-(2-(pyrrolyl) thiophenyl)-1, 2, 4-oxadiazoles as potential antitumor molecules on breast cancer MCF-7 cells.
    Abd El Hameid MK; Mohammed MR
    Bioorg Chem; 2019 May; 86():609-623. PubMed ID: 30807934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors.
    Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A
    Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy.
    Shamsi F; Hasan P; Queen A; Hussain A; Khan P; Zeya B; King HM; Rana S; Garrison J; Alajmi MF; Rizvi MMA; Zahid M; Imtaiyaz Hassan M; Abid M
    Bioorg Chem; 2020 May; 98():103754. PubMed ID: 32200329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
    Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
    Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
    Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
    Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J; Khalilzadeh MA; Zareyee D
    Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel 1,3,4-Triaryl Pyrazoles: Synthesis, QSAR Studies and Cytotoxicity against Breast Cancer.
    Ismail MMF; Farrag AM; Harras MF
    Anticancer Agents Med Chem; 2019; 19(7):948-959. PubMed ID: 30727920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR
    Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH
    Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
    Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
    Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
    Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
    Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
    Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
    Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
    Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.